Cardiac Arrhythmia Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Arrhythmia Monitoring Devices Market is Segmented by Devices (Event Monitoring Devices, Continuous Rhythm Monitoring Devices, Holter Monitoring Devices, and Other Devices), Service Providers (Mobile Cardiac Telemetry Monitoring Service Providers and Independent Diagnostic Testing Facilities/Clinics), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The market provides the value (in USD million) for the above-mentioned segments.

Cardiac Arrhythmia Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cardiac Arrhythmia Monitoring Devices Market Size

Cardiac Arrhythmia Monitoring Devices Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 8.86 Billion
Market Size (2030) USD 12.82 Billion
CAGR (2025 - 2030) 7.67 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Cardiac Arrhythmia Monitoring Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Cardiac Arrhythmia Monitoring Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cardiac Arrhythmia Monitoring Devices Market Analysis

The Cardiac Arrhythmia Monitoring Devices Market size is estimated at USD 8.86 billion in 2025, and is expected to reach USD 12.82 billion by 2030, at a CAGR of 7.67% during the forecast period (2025-2030).

The COVID-19 pandemic has significantly impacted the cardiac arrhythmia monitoring market as several inpatient and outpatient cardiac procedures were postponed or delayed. As a result, the diagnosis of patients suffering from arrhythmias was substantially reduced. However, due to the emerging cardiac complications associated with COVID-19, the demand for arrhythmia monitoring devices is set to increase in the future. For instance, as per a July 2020 published article titled "COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives", COVID-19 patients with underlying cardiovascular comorbidities have high mortality. The same source also reported that arrhythmias and sudden cardiac arrest are common manifestations of COVID-19. As per a December 2020 published article titled "Incidence rate and clinical impacts of arrhythmia following COVID-19: a systematic review and meta-analysis of 17,435 patients", arrhythmia is a potential cardiovascular complication of COVID-19. As per the study, in one case series of patients hospitalized with COVID-19, 16.7% developed unspecified arrhythmia. Thus, the demand for cardiac arrhythmia monitoring devices is anticipated to increase over the coming years.

Further, the market's growth can be largely attributed to the increasing use of telecardiology, ease of use and portability of cardiac arrhythmia monitoring devices, and the development of smart cardiac monitors.

Increasing usage of telecardiology is a major factor driving the market's growth. Telecardiology, in general, provides a monitoring device that can be fixed on the chest area of patients suffering from cardiac arrhythmia. Telecardiology is a cost-effective intervention for the elderly population affected by heart failure. Thus, the adoption of telecardiology is increasing. Several companies are launching their telecardiology services, propelling the market's growth. For instance, in December 2020, Coala Life launched a direct-to-patient telecardiology service. The product is a patch-free, smartphone-powered electrocardiogram (ECG) monitor that provides diagnostic quality and real-time detection of the most common cardiac arrhythmias.

The ease of use and portability of cardiac arrhythmia monitoring devices is one of the major factors driving the market's growth. For instance, in February 2021, RhythMedix launched its next-generation wearable novel cardiac telemetry monitor with built-in 4G cellular connectivity for arrhythmia detection. Thus, such developments may fuel the development of more types of similar cardiac monitors that are easy to carry and portable, thereby fueling the market's growth.

Nonetheless, poor adoption of telemetry technology in emerging markets and the high cost of remote cardiac arrhythmia monitoring devices are hindering the market's growth.

Cardiac Arrhythmia Monitoring Devices Industry Overview

The cardiac arrhythmia monitoring market is moderately competitive, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Abbott, GE Healthcare, Medtronic PLC, Koninklijke Philips NV, and ACS Diagnostics.

Cardiac Arrhythmia Monitoring Devices Market Leaders

  1. Abbott

  2. Medtronic PLC

  3. ACSDiangostics

  4. GE Healthcare

  5. Koninklijke Philips NV

  6. *Disclaimer: Major Players sorted in no particular order
Cardiac Arrhythmia Monitoring Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cardiac Arrhythmia Monitoring Devices Market News

In November 2021, Philips agreed to acquire Cardiologs, a France-based medical technology company focused on cardiac diagnostics using AI and cloud technology. The acquisition will strengthen Philips' cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis, and reporting services.

In May 2021, iRhythm Technologies Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, received two new 510(k) clearances, one for a new and improved design of its flagship monitor, "new Zio monitor", and a second for updated AI capabilities.

Cardiac Arrhythmia Monitoring Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Use of Telecardiology
    • 4.2.2 Ease of Use and Portability of Cardiac Arrhythmia Monitoring Devices
    • 4.2.3 Development of Smart Cardiac Monitors
  • 4.3 Market Restraints
    • 4.3.1 Poor Adoption of Telemetry Technology in Emerging Markets
    • 4.3.2 High Cost of Remote Cardiac Arrhythmia Monitoring
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Devices
    • 5.1.1 Event Monitoring Devices
    • 5.1.2 Continuous Rhythm Monitoring Devices
    • 5.1.3 Holter Monitoring Devices
    • 5.1.4 Other Devices
  • 5.2 By Service Providers
    • 5.2.1 Mobile Cardiac Telemetry Monitoring Service Providers
    • 5.2.2 Independent Diagnostic Testing Facilities/Clinics
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ACSDiagnostics
    • 6.1.2 AliveCor Inc.
    • 6.1.3 Abbott Laboratories
    • 6.1.4 Biotronik
    • 6.1.5 GE Healthcare
    • 6.1.6 iRhythm Technologies Inc.
    • 6.1.7 Medi-Lynx
    • 6.1.8 Medtronic PLC
    • 6.1.9 Koninklijke Philips NV
    • 6.1.10 Welch Allyn
    • 6.1.11 Spacelabs Healthcare Inc.
    • 6.1.12 Fukuda Denshi
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cardiac Arrhythmia Monitoring Devices Industry Segmentation

As per the scope of the report, cardiac arrhythmia monitoring devices are used for monitoring patients at risk or with heart arrhythmia. These devices detect and alarm irregular heartbeats that are either too slow or too fast. The market is segmented by devices, service providers, and geography. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the above segments.

By Devices Event Monitoring Devices
Continuous Rhythm Monitoring Devices
Holter Monitoring Devices
Other Devices
By Service Providers Mobile Cardiac Telemetry Monitoring Service Providers
Independent Diagnostic Testing Facilities/Clinics
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cardiac Arrhythmia Monitoring Devices Market Research FAQs

How big is the Cardiac Arrhythmia Monitoring Devices Market?

The Cardiac Arrhythmia Monitoring Devices Market size is expected to reach USD 8.86 billion in 2025 and grow at a CAGR of 7.67% to reach USD 12.82 billion by 2030.

What is the current Cardiac Arrhythmia Monitoring Devices Market size?

In 2025, the Cardiac Arrhythmia Monitoring Devices Market size is expected to reach USD 8.86 billion.

Who are the key players in Cardiac Arrhythmia Monitoring Devices Market?

Abbott, Medtronic PLC, ACSDiangostics, GE Healthcare and Koninklijke Philips NV are the major companies operating in the Cardiac Arrhythmia Monitoring Devices Market.

Which is the fastest growing region in Cardiac Arrhythmia Monitoring Devices Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Cardiac Arrhythmia Monitoring Devices Market?

In 2025, the North America accounts for the largest market share in Cardiac Arrhythmia Monitoring Devices Market.

What years does this Cardiac Arrhythmia Monitoring Devices Market cover, and what was the market size in 2024?

In 2024, the Cardiac Arrhythmia Monitoring Devices Market size was estimated at USD 8.18 billion. The report covers the Cardiac Arrhythmia Monitoring Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Cardiac Arrhythmia Monitoring Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Arrhythmia Monitoring Devices Industry Report

Statistics for the 2025 Cardiac Arrhythmia Monitoring Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cardiac Arrhythmia Monitoring Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.